Latest debt-to-equity ratio
Regeneron Pharmaceuticals Debt-to-equity ratio
Direct answer
Regeneron Pharmaceuticals's debt-to-equity ratio is 8.54%.
The verified market snapshot reports 8.54%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 30, 2026.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 8.54%
Explore related company data
View Regeneron Pharmaceuticals's market capitalizationView Regeneron Pharmaceuticals's p/e ratioView Regeneron Pharmaceuticals's price-to-book ratioView Regeneron Pharmaceuticals's return on equityView Regeneron Pharmaceuticals's dividend yieldView Regeneron Pharmaceuticals's 52-week price rangeView Regeneron Pharmaceuticals's revenue growthView Regeneron Pharmaceuticals's profit marginView all Regeneron Pharmaceuticals key metricsReturn to Regeneron Pharmaceuticals profile